Latest filing published 21 Dec 2022 for Forward Industries, Inc., €5,323.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sharon Hemond Hrynkow: trading record in brief
This profile gathers the share dealings of Sharon Hemond Hrynkow across 2 companies, led by Cyclo Therapeutics, Inc. and Forward Industries, Inc. Over a trading history stretching from 21 December 2018 to 20 December 2022, the count stands at 14 filings.
On the market, this insider has only ever bought: 10 purchases, €26k in total. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants. 2022 to date brings 2 purchases and no sales.
The median purchase comes to €3,046. Clusters matter here: 8 out of 8 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 21 December 2022: an open-market purchase of €5,306, in Forward Industries, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sharon Hemond Hrynkow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.13100.0% of flowCommon StockSEC:0001683168-22-008580:0Canonical exit: 20 Mar 2023 (T+90)
- 1,000 shares@ US$4.98100.0% of flowCommon StockSEC:0001437749-21-027716:0Canonical exit: 2 Mar 2022 (T+90)
2 of 2 declarations
